Drugs · acquisition-cost intelligence
Adult Tussin
Guaifenesin· ingredient guaifenesin· GUAIFENESIN 100 mg/5mL; GUAIFENESIN 200 mg/10mL; GUAIFENESIN 300 mg/15mL; GUAIFENESIN 400 mg/20mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.01815
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 7 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other guaifenesin products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Leader Adult Tussin Mucus and Chest Congestion 541 | $0.02236 | +$0.00420 |
| Guaifenesin 200mg | $0.03140 | +$0.01320 |
| Always Save Chest Congestion Relief GUAF | $0.06723 | +$0.04910 |
| Always Save Mucus Relief PE | $0.08718 | +$0.06900 |
| 12 Hour Mucus Relief | $0.29751 | +$0.27940 |
| equate mucus d | $0.36492 | +$0.34680 |
| EQUATE MUCUS D | $0.41980 | +$0.40170 |
| basic care mucus er max | $0.44813 | +$0.43000 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.